BSERECODE STUDIOS LIMITED· Personal ProductsHighPositive
Announced Tue, 14 Jul, 2026 · 18:33 IST

Recode Studios to acquire 51 percent stake in Aflairza Professionals

Listed Co AcquisitionStrategic Transactions View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+8.8%Reaction day
₹180.00
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.6%+8.1% vs market
Personal Care peers, median of 14sector-0.6%+9.4% vs sector

On the reaction day the stock moved 8.1 pts more than Nifty Microcap 250 and 9.4 pts more than its Personal Care peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+8.8+0.6+8.1-0.6+9.4
Next day
+17.5+0.2+17.3-0.8+18.3
2d
+14.0-0.9+14.9-1.2+15.2
3d
+15.6-0.3+15.9-2.1+17.6
4d
+14.4+0.0+14.4-1.4+15.9
5d
+20.6-1.1+21.7-1.1+21.7
1w
+21.7-1.4+23.1-1.0+22.7
15d
+25.8+2.7+23.2-2.5+28.3
1m
+65.6+3.6+62.0-3.4+68.9
2m
+111.1+2.0+109.1-10.1+121.2
3m
+141.1+1.1+140.0-10.5+151.6
UpDownMarket · Nifty Microcap 250Sector · Personal Care peers, median of 14Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Recode Studios signed a term sheet to acquire up to 51 percent in premium beauty brand Aflairza Professionals. Phase I is 33 percent for Rs 8.32 crore, split between promoter share purchase and fresh capital. Phase II lifts it to 51 percent after milestones. Aflairza uses Korean formulations; promoters continue running ops while Recode adds a board nominee.

Likely market impact

Positive: strategic expansion into premium beauty segment. Small Phase I deal of Rs 8.32 crore limits near-term dilution. Watch milestone progress to 51%.